Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

BAT IT: Banked Anti-SARS Cov-2 T Cell Infusions for Treatment of COVID 19

Trial Profile

BAT IT: Banked Anti-SARS Cov-2 T Cell Infusions for Treatment of COVID 19

Status: Discontinued
Phase of Trial: Phase I

Latest Information Update: 04 May 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs ALVR 109 (Primary)
  • Indications COVID 2019 infections; SARS-CoV-2 acute respiratory disease
  • Focus Adverse reactions; Proof of concept; Therapeutic Use
  • Acronyms BATIT
  • Sponsors AlloVir
  • Most Recent Events

    • 16 Dec 2021 Status changed from active, no longer recruiting to discontinued. Reason the study was stopped : due to trial's eligibility criteria and the low census of hospitalized COVID-19 patients meeting eligibility criteria, the Sponsor will be unable to enroll a meaningful number of patients in this single-center trial in a reasonable time frame.
    • 03 Nov 2021 Planned End Date changed from 15 Aug 2021 to 15 Jan 2022.
    • 03 Nov 2021 Planned primary completion date changed from 15 Aug 2021 to 15 Jan 2022.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top